Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29, p.viii313-viii313 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | viii313 |
|---|---|
| container_issue | |
| container_start_page | viii313 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Procopio, G. Bamias, A. Schmidinger, M. Hawkins, R. Rodriguez Sanchez, A. Vazquez, S. Srihari, N. Kalofonos, H. Bono, P. Pisal, C. Hirschberg, Y. Dezzani, L. Ahmad, Q. Suarez Rodriguez, C. Jonasch, E. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy283.093 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy283_093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419492739</els_id><sourcerecordid>S0923753419492739</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2303-e1fd341e6c032583d875413df4da55f5dfdea988a31dd264a77197260d0e98623</originalsourceid><addsrcrecordid>eNp9kMtLAzEQxoMotj7-AC-Sox7W5rGv4KkUH4WiInpe0mSi0W2yJGulXv3Hjax69DLDfMw3zPdD6IiSM0oEn0jnvFOTld6wmp8lZQuNaVGKrCY53UZjIhjPqoLnI7QX4wshpBRM7KIRZ5SXFRNj9HkPss3efWg1BmNA9XYNDmLE3uBOfvhOOrvE1qWht-D6iN9t_5yEHsIKtJU94C74J-djbxUONr5iqdfSKdA4gJMtVtCmIoOyzq8kPrm7n9_M5nfTBY79m96cHqAdI9sIhz99Hz1eXjzMrrPF7dV8Nl1kinHCM6BG85xCqQhnRc11XRU55drkWhaFKbTRIEVdS061ZmUuq4qKipVEExB1yfg-osNdFXyMAUzTBbuSYdNQ0nwDbQagzQC0SUryHA-e7m2Z4v45fgmmhfNhAdLnawuhiSpxSultSDQb7e0_578ACAmKvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Procopio, G. ; Bamias, A. ; Schmidinger, M. ; Hawkins, R. ; Rodriguez Sanchez, A. ; Vazquez, S. ; Srihari, N. ; Kalofonos, H. ; Bono, P. ; Pisal, C. ; Hirschberg, Y. ; Dezzani, L. ; Ahmad, Q. ; Suarez Rodriguez, C. ; Jonasch, E.</creator><creatorcontrib>Procopio, G. ; Bamias, A. ; Schmidinger, M. ; Hawkins, R. ; Rodriguez Sanchez, A. ; Vazquez, S. ; Srihari, N. ; Kalofonos, H. ; Bono, P. ; Pisal, C. ; Hirschberg, Y. ; Dezzani, L. ; Ahmad, Q. ; Suarez Rodriguez, C. ; Jonasch, E.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy283.093</identifier><identifier>PMID: 32136729</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii313-viii313</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32136729$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Procopio, G.</creatorcontrib><creatorcontrib>Bamias, A.</creatorcontrib><creatorcontrib>Schmidinger, M.</creatorcontrib><creatorcontrib>Hawkins, R.</creatorcontrib><creatorcontrib>Rodriguez Sanchez, A.</creatorcontrib><creatorcontrib>Vazquez, S.</creatorcontrib><creatorcontrib>Srihari, N.</creatorcontrib><creatorcontrib>Kalofonos, H.</creatorcontrib><creatorcontrib>Bono, P.</creatorcontrib><creatorcontrib>Pisal, C.</creatorcontrib><creatorcontrib>Hirschberg, Y.</creatorcontrib><creatorcontrib>Dezzani, L.</creatorcontrib><creatorcontrib>Ahmad, Q.</creatorcontrib><creatorcontrib>Suarez Rodriguez, C.</creatorcontrib><creatorcontrib>Jonasch, E.</creatorcontrib><title>Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMtLAzEQxoMotj7-AC-Sox7W5rGv4KkUH4WiInpe0mSi0W2yJGulXv3Hjax69DLDfMw3zPdD6IiSM0oEn0jnvFOTld6wmp8lZQuNaVGKrCY53UZjIhjPqoLnI7QX4wshpBRM7KIRZ5SXFRNj9HkPss3efWg1BmNA9XYNDmLE3uBOfvhOOrvE1qWht-D6iN9t_5yEHsIKtJU94C74J-djbxUONr5iqdfSKdA4gJMtVtCmIoOyzq8kPrm7n9_M5nfTBY79m96cHqAdI9sIhz99Hz1eXjzMrrPF7dV8Nl1kinHCM6BG85xCqQhnRc11XRU55drkWhaFKbTRIEVdS061ZmUuq4qKipVEExB1yfg-osNdFXyMAUzTBbuSYdNQ0nwDbQagzQC0SUryHA-e7m2Z4v45fgmmhfNhAdLnawuhiSpxSultSDQb7e0_578ACAmKvA</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Procopio, G.</creator><creator>Bamias, A.</creator><creator>Schmidinger, M.</creator><creator>Hawkins, R.</creator><creator>Rodriguez Sanchez, A.</creator><creator>Vazquez, S.</creator><creator>Srihari, N.</creator><creator>Kalofonos, H.</creator><creator>Bono, P.</creator><creator>Pisal, C.</creator><creator>Hirschberg, Y.</creator><creator>Dezzani, L.</creator><creator>Ahmad, Q.</creator><creator>Suarez Rodriguez, C.</creator><creator>Jonasch, E.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)</title><author>Procopio, G. ; Bamias, A. ; Schmidinger, M. ; Hawkins, R. ; Rodriguez Sanchez, A. ; Vazquez, S. ; Srihari, N. ; Kalofonos, H. ; Bono, P. ; Pisal, C. ; Hirschberg, Y. ; Dezzani, L. ; Ahmad, Q. ; Suarez Rodriguez, C. ; Jonasch, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2303-e1fd341e6c032583d875413df4da55f5dfdea988a31dd264a77197260d0e98623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Procopio, G.</creatorcontrib><creatorcontrib>Bamias, A.</creatorcontrib><creatorcontrib>Schmidinger, M.</creatorcontrib><creatorcontrib>Hawkins, R.</creatorcontrib><creatorcontrib>Rodriguez Sanchez, A.</creatorcontrib><creatorcontrib>Vazquez, S.</creatorcontrib><creatorcontrib>Srihari, N.</creatorcontrib><creatorcontrib>Kalofonos, H.</creatorcontrib><creatorcontrib>Bono, P.</creatorcontrib><creatorcontrib>Pisal, C.</creatorcontrib><creatorcontrib>Hirschberg, Y.</creatorcontrib><creatorcontrib>Dezzani, L.</creatorcontrib><creatorcontrib>Ahmad, Q.</creatorcontrib><creatorcontrib>Suarez Rodriguez, C.</creatorcontrib><creatorcontrib>Jonasch, E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Procopio, G.</au><au>Bamias, A.</au><au>Schmidinger, M.</au><au>Hawkins, R.</au><au>Rodriguez Sanchez, A.</au><au>Vazquez, S.</au><au>Srihari, N.</au><au>Kalofonos, H.</au><au>Bono, P.</au><au>Pisal, C.</au><au>Hirschberg, Y.</au><au>Dezzani, L.</au><au>Ahmad, Q.</au><au>Suarez Rodriguez, C.</au><au>Jonasch, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii313</spage><epage>viii313</epage><pages>viii313-viii313</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32136729</pmid><doi>10.1093/annonc/mdy283.093</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29, p.viii313-viii313 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy283_093 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A29%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real-world%20effectiveness%20of%20pazopanib%20in%20patients%20with%20intermediate%20prognostic%20risk%20advanced%20renal%20cell%20carcinoma%20(PRINCIPAL%20study)&rft.jtitle=Annals%20of%20oncology&rft.au=Procopio,%20G.&rft.date=2018-10&rft.volume=29&rft.spage=viii313&rft.epage=viii313&rft.pages=viii313-viii313&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy283.093&rft_dat=%3Celsevier_cross%3ES0923753419492739%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32136729&rft_els_id=S0923753419492739&rfr_iscdi=true |